GE HealthCare Technologies Inc. $GEHC Shares Purchased by Cibc World Market Inc.

Cibc World Market Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 24.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 98,863 shares of the company’s stock after buying an additional 19,534 shares during the period. Cibc World Market Inc.’s holdings in GE HealthCare Technologies were worth $6,463,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. Ritholtz Wealth Management bought a new position in GE HealthCare Technologies during the third quarter valued at about $1,285,000. Northside Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 26.5% during the second quarter. Northside Capital Management LLC now owns 241,923 shares of the company’s stock valued at $15,485,000 after acquiring an additional 50,634 shares during the period. TD Waterhouse Canada Inc. boosted its position in GE HealthCare Technologies by 5.1% in the third quarter. TD Waterhouse Canada Inc. now owns 608,890 shares of the company’s stock valued at $39,015,000 after buying an additional 29,752 shares in the last quarter. Hsbc Holdings PLC lifted its position in GE HealthCare Technologies by 22.8% during the 2nd quarter. Hsbc Holdings PLC now owns 1,004,490 shares of the company’s stock worth $64,217,000 after buying an additional 186,800 shares in the last quarter. Finally, Trian Fund Management L.P. grew its stake in shares of GE HealthCare Technologies by 76,194.4% during the second quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock valued at $197,493,000 after purchasing an additional 3,081,300 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Wolfe Research started coverage on GE HealthCare Technologies in a research note on Tuesday, October 20th. They set a “peer perform” rating for the company. Barclays boosted their price objective on GE HealthCare Technologies from $85.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, October 29th. Needham & Company LLC reaffirmed a “buy” rating and issued a $93.00 price target on shares of GE HealthCare Technologies in a research note on Monday, October 5th. Royal Bank Of Canada upped their price target on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, October 29th. Finally, UBS Group increased their price objective on shares of GE HealthCare Technologies from $73.00 to $80.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 3rd. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $82.52.

Check Out Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Trading Down 1.6%

NASDAQ:GEHC opened at $80.54 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 1.01, a current ratio of 1.30 and a debt-to-equity ratio of 0.86. The business has a 50 day moving average price of $72.19 and a two-hundred day moving average price of $70.19. The company has a market cap of $36.42 billion, a P/E ratio of 16.99, a price-to-earnings-growth ratio of 2.03 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The company had revenue of $5.51 billion for the quarter, compared to the consensus estimate of $5.35 billion. During the same period last year, the company earned $1.07 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. As a group, analysts expect that GE HealthCare Technologies Inc. will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Friday, October 23rd were given a dividend of $0.04 per share. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date of this dividend was Friday, October 23rd. This represents a $0.16 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.38%.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Featured Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.